Pharmaceutical giant Pfizer announced last month the abrupt departure of General Counsel Amy Schulman, who will not assume the role of group president of the vaccines, oncology and consumer healthcare business as originally planned.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...